Docebo (DCBO) Common Equity (2020 - 2026)

Docebo has reported Common Equity for 7 years, with the latest figure at -$616000.0 in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 101.17% year-over-year to -$616000.0; the trailing twelve-month figure through Mar 2026 stood at -$616000.0 (down 101.17% YoY), and the FY2025 full-year result was $74.1 million, up 28.27% from the prior year.
• Common Equity for Q1 2026 stood at -$616000.0, down from $74.1 million in the prior quarter.
• The five-year high for Common Equity was $195.2 million in Q1 2023, with the low at -$616000.0 in Q1 2026.
• Historically, Common Equity has averaged $103.0 million across 5 years, with a median of $66.9 million in 2024.
• Annual changes were most pronounced in 2025 — Common Equity increased 28.27% — and 2026, when it plunged 101.17%.
• Docebo's Common Equity stood at $192.2 million in 2022, then tumbled by 73.61% to $50.7 million in 2023, then advanced by 13.88% to $57.8 million in 2024, then gained by 28.27% to $74.1 million in 2025, then tumbled by 100.83% to -$616000.0 in 2026.
• The last three Common Equity figures came in at -$616000.0 (Q1 2026), $74.1 million (Q4 2025), and $34.7 million (Q2 2025), per Business Quant data.